Showing 711-720 of 3412 results for "".
Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Epidermal Inclusion Cysts: Dr. Goldman
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/epidermal-inclusion-cysts-dr-goldman/32687/Mitchel Goldman, MD, who took part in the "Neuromodulator and Dermal Filler" panel at Maui Derm 2025, talks about a new treatment for epidermal inclusion cysts, involving sclerotherapy medication."You've Just Been Served": Dr. Goldberg
https://practicaldermatology.com/programs/practical-dermatology/youve-just-been-served-dr-goldberg/32691/David Goldberg, MD, JD, discusses lessening the likelihood of lawsuits and winning lawsuits involving negligence, employees, and teledermatology, which he covered during his session, "You've Just Been Served," at Maui Derm 2025.Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/series/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.What's New in Topical Treatment for Plaque Psoriasis?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-in-topical-treatment-for-plaque-psoriasis/20235/Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, discusses what’s new in topical treatment of plaque psoriasis and the importance of an “elegant vehicle” for patients to use in their care regimens.Modifying Masseters and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/modifying-masseters-and-more/19698/Artful use of neurotoxin in the masseters and parotid glands can help thin the appearance of the face. Chytra Anand, MD discusses her approach and talks about treatments used in her home country of India.Considering Aesthetic Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/considering-aesthetic-combinations/19684/Whether it's the use of two or more devices or the addition of fillers or neurotoxins to device-based treatments, combination approaches can improve outcomes and potentially reduce downtime, Nazanin Saedi, MD explains.Antiaging Medicine Meets Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/antiaging-medicine-meets-aesthetics/18883/Antiaging medicine supports overall patient health and can be a complement to aesthetic medicine. Greg Buford, MD talks about anti aging medicine and its role in his practice.Positive Changes in My Practice
https://practicaldermatology.com/topics/practice-management/positive-changes-in-my-practice/19044/Sometimes relatively simple changes can have a big impact on a practice. Steve Yoelin, MD talks about positive changes he has made in his practice.Management of the Periocular Area
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/management-of-the-periocular-area/19210/Richard Anderson, MD reviews his presentation on the proper approach to cosmetic management of the periocular area and mid-face at Vegas Cosmetic Surgery 2013. He discusses blepharoplasty, toxins, fillers, and more. VCS2013